
Mary E Brunkow, Fred Ramsdell and Shimon Sakaguchi are awarded this year's Nobel Prize in Medicine or Physiology. The Nobel Assembly at Karolinska Institutet announce the Nobel Prize in Physiology or Medicine on October 6, 2025, in Stockholm, Sweden.— Reuters
#Nobel #medicine #prize #researchers #immune #system #precision
Japan -based American scientists Mary Burko and Fred Ramsidel and Simon Sakaguchi worked on Monday to win the 2025 Nobel Prize in Physiology or Medicine, how the immune system saves healthy cells, which potentially produces new autoimmune and cancer treatment.
This year’s prize is related to the immune tolerance, or “how do we control our immune system so that we can withstand all fantastic microbes and still avoid automatic disease,” said Mary Wahran Harlinis, a professor of rheumatology at the Corolnska Institute, said Mary Wahran Harlinis.
“I think this is a great honor,” according to the Kyodo News Agency, Sakaguchi told reporters outside his university laboratory.
Regulatory T cells: ‘Security Guards’ of the immune system
The winners for Madison are chosen by the Nobel Assembly of the Corolneska Institute of Sweden in Sweden and they receive a gold medal offered by the 11 million Swedish crown ($ 1.2 million) as well as the King of Sweden.
Burko is a senior program manager at the Institute for Systems Biology at Seattle, while Ramsaddal is a scientific adviser at Sonoma Biochemotics in San Francisco. Sakaguchi is a professor at Osaka University in Japan.
“His discoveries have laid the foundation for a new field of research and promoted the development of new treatment, for example for cancer and autoimmune diseases.”
He added that awardees identified the so -called regulatory T cells, which serve as security guards of the immune system that prevent immune cells from attacking our own bodies.
After announcing the winners, the Institute’s Thomas Pearlman said that the market clearance is still yet to be won, but more than 200 trials are underway on humans involved in the regulatory T cells.
In early race companies, Sonoma Bio.rapatic, which is founded by Ramsidel, is partially financed, opens a new tab and supported by US drug maker Regenron, for the treatment of inflammatory acids.
Targeting this condition, Quail therapatics, Opens New Tab, has contributed with Austra Zenika, opens a new tab.
Other bayotic firms that look for this approach open the new tab, opens a new tab.
The first prize of the medicine Noble Season
The Nobel Prizes were established by the will of Alfred Noble, who was the Swedish inventor of Dynamite and a wealthy businessman. He has been awarded a significant contribution to science, literature and peace since 1901, primarily with obstacles during World War I.
The Economics Prize was later included and financed by Sweden’s Central Bank, Rix Bank.
The winners are selected by expert committees of various institutions. All awards are given in the Stockholm, except for the Peace Prize, which is presented in Oslo – a potential legacy of a political alliance between Sweden and Norway during Nobel life.
The recipients of the Nobel Prize in Physiology or Medicine include a famous scientist like Alexander Fleming, who shared the 1945 award to discover Pennsylon. In recent years, the award has acknowledged great achievements, including those who have enabled the development of the Kovide 19 vaccine.
Last year’s Medicine Prize was given to US scientists to Victor Ambros and Gary Rokon for the discovery of micro -RNA and how multi -cellular organisms develop and how to survive, explaining how the cells specialize in different types.
According to tradition, the drug launches annual noobs, which are the most favorable rewards of science, literature, peace and economics, which is announced in the coming days.
More than a century after his establishment, the Nobel rewards remain according to the tradition. The awards concluded by the royal families of Sweden and Norway, followed by the anniversary of the death of Alfred Nobel on December 10.